Risk of Cardiovascular Morbidity With Risperidone or Paliperidone Treatment: Analysis of 64 Randomized, Double-Blind Trials

A post hoc analysis of the risperidone (RIS)/paliperidone (Pali) clinical trials database comprising 64 studies was conducted. Risk of sudden death, cardiovascular (CV), and cerebrovascular events during RIS or Pali treatment was estimated. Treatment emergent CV adverse events were identified using...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical psychopharmacology 2013-04, Vol.33 (2), p.157-161
Hauptverfasser:	GOPAL, Srihari, HOUGH, David, KARCHER, Keith, NUAMAH, Isaac, PALUMBO, Joseph, BERLIN, Jesse A, BASEMAN, Alan, YIMEI XU, KENT, Justine
Format:	Artikel
Sprache:	eng
Schlagworte:	Antipsychotic Agents - adverse effects Biological and medical sciences Cardiovascular Diseases - chemically induced Cardiovascular Diseases - epidemiology Cardiovascular Diseases - physiopathology Databases, Factual Drug Labeling Humans Incidence Isoxazoles - adverse effects Medical sciences Neuropharmacology Paliperidone Palmitate Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Pyrimidines - adverse effects Randomized Controlled Trials as Topic Risk Risperidone - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!